Development and profiling of mGlu7 NAMs with a range of saturable inhibition of agonist responses in vitro is a research paper published in Bioorganic & Medicinal Chemistry Letters (2022). On theSindex it has a DataRank of 0.208. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.208
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Mental Health
Grant: MH102548
Congressionally Directed Medical Research Programs
Grant: MH113543
Congressionally Directed Medical Research Programs
Grant: MH124671
Congressionally Directed Medical Research Programs
Grant: W81XWH-17-1-0266
NIMH NIH HHS
Grant: R01 MH113543
NIMH NIH HHS
Grant: R01 MH124671
NIMH NIH HHS
Grant: R21 MH102548
National Institutes of Health
FWCI
0.27
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals